Hormone therapy litigation has grown steadily over the past decade, and 2026 is no exception. Cases involving testosterone replacement, estrogen therapy, GLP-1 agonists, peptides, and regenerative medicine are reaching courts and arbitration panels with increasing frequency — and the quality of the expert witness often determines whether a case settles favorably or falls apart under cross-examination.
This guide addresses the questions attorneys and insurers ask most often when sourcing a hormone therapy expert witness: what qualifications actually matter, how the litigation landscape has shifted, where standard referral channels fall short, and what a subspecialty-matched, directly retained endocrinologist brings to a case.
What Qualifies Someone as a Hormone Therapy Expert Witness?
Does board certification matter for hormone therapy cases?
Yes — and subspecialty certification matters more than general medical licensure. A board-certified endocrinologist has completed fellowship training specifically in the endocrine system: hormones, metabolism, and the glands that regulate them. That credential signals to a court that the witness holds formal, examined expertise in the biological mechanisms at the center of the dispute, not just incidental clinical exposure.
What else should attorneys look for beyond board certification?
A defensible opinion requires more than credentials. Look for a published academic record in the relevant hormone class, documented deposition or courtroom experience, and the ability to translate complex endocrinology into language a judge or jury can follow. An expert who has only treated patients but never been deposed will struggle when opposing counsel probes the basis of their opinions.
Why does subspecialty matching matter so much?
Hormone therapy is not a single category. Testosterone replacement, GLP-1 receptor agonists, estrogen and progesterone protocols, thyroid management, growth hormone, and peptide administration each carry distinct pharmacology, dosing standards, and risk profiles. An expert whose clinical and research background aligns with the specific hormone class in dispute will produce a more precise standard-of-care opinion — and hold up better when it counts.
How Has Hormone Therapy Litigation Evolved?
Is testosterone therapy litigation still growing?
The legal record on testosterone therapy lawsuits against prescribers spans more than two decades. A review of cases from 2000 through 2024 published on PubMed documents the trajectory of testosterone-related litigation, with recurring themes around inadequate informed consent, off-label prescribing, cardiovascular risk disclosure, and monitoring failures. That body of case law now gives both plaintiff and defense counsel a clearer framework for arguing — and challenging — standard of care.
What about HRT and menopause-related cases?
Litigation involving estrogen and combined hormone replacement therapy has followed a similar arc, shaped in part by shifting clinical guidelines and evolving evidence on cardiovascular and oncologic risk. As prescribing patterns change — particularly with renewed interest in menopause management — new cases are emerging around dosing decisions, contraindication screening, and long-term monitoring obligations.
Are GLP-1 agonists and newer agents generating litigation?
GLP-1 receptor agonists have moved from diabetes management into widespread use for weight loss, and that rapid expansion has opened a new litigation frontier. Questions around off-label prescribing, compounded formulations, patient selection, and adverse event disclosure are already appearing in pre-litigation demands and early filings. Peptide therapy and regenerative medicine cases are following a similar pattern as these treatments move from specialty clinics into broader practice.
How Do Attorneys and Insurers Typically Find Hormone Therapy Experts?
What role do expert witness directories play?
Directories like SEAK and JurisPro provide searchable databases of experts across hundreds of specialties. They are a reasonable starting point for identifying candidates, but they function as listings — not vetting services. A directory confirms that an expert has registered a profile; it does not confirm that their subspecialty background aligns with the specific hormone class in dispute, that their opinions have survived Daubert challenges, or that they are available on your timeline.
What about expert witness brokers and staffing firms?
Firms like IMS Legal Strategies and Homestead Experts add a layer of case-matching and coordination, which can be useful in generalist matters. In subspecialty-intensive hormone therapy cases, however, a broker may lack the clinical knowledge to distinguish between an endocrinologist who primarily manages diabetes and one whose practice and publications center on hormone replacement, peptides, or anabolic steroid misuse. The intermediary layer can also slow engagement and add cost without adding clinical precision.
What is the alternative to directories and brokers?
Directly retaining a subspecialty-matched expert — without an intermediary — gives counsel a cleaner engagement, faster turnaround on record reviews, and an expert who is accountable to the case rather than to a referral relationship. It also allows for a direct conversation about the specific hormone class, the applicable standard of care, and the defensibility of the opinion before any formal retention.
What Does a Dedicated Hormone Therapy Expert Witness Practice Look Like?
How does hormon.ai address the subspecialty gap?
hormon.ai is the medicolegal practice of Dr. Fady Hannah-Shmouni, a board-certified endocrinologist whose expert services cover testosterone replacement therapy, estrogen and progesterone protocols, thyroid management, growth hormone, GLP-1 agonists, peptides, anabolic steroids, regenerative medicine, and agentic AI liability in clinical settings. That breadth within endocrinology means the practice engages on the specific hormone class in dispute rather than offering a generalist opinion that opposing counsel can attack for lack of precision.
What types of engagements does the practice handle?
The practice serves plaintiff counsel, defense counsel, insurers, and regulatory bodies. Engagements include medical record reviews, written standard-of-care opinions, and testimony at deposition or trial. Every written opinion is prepared to withstand cross-examination — the reasoning is documented, the evidentiary basis is explicit, and the conclusions are grounded in published clinical standards.
What does expert witness work in this specialty typically cost?
Industry benchmarks published by Expert Institute place endocrinology expert witness fees at approximately $356 to $478 per hour depending on the nature of the engagement, with some subspecialists billing at or above $448 per hour for deposition and trial work. These figures reflect market rates across the field and are not confirmed rates for any specific practice. Attorneys and insurers should request a fee schedule directly when evaluating any expert.
Hormone therapy cases are technically demanding, and the expert you retain will shape how the case is argued, how it survives motions, and how it holds up at trial. Subspecialty alignment is not a preference — it is a practical requirement for producing opinions that hold.
To discuss a current or anticipated matter, enquire directly at hormon.ai.